Decreased muscarinic binding sites in small intestine from mice treated with neostigmine.
D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D001286:Atropine Derivatives / Q000633:toxicity; D002217:Carbachol / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051379:Mice; D009388:Neostigmine / Q000494:pharmacology*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000378:metabolism*; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism*
D001286:Atropine Derivatives; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D009388:Neostigmine; D011813:Quinuclidinyl Benzilate; C006649:methylatropine; D002217:Carbachol; D000110:Acetylcholinesterase